28
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Celecoxib, a cyclooxygenase-2 inhibitor, improved upper gastrointestinal lesions in rheumatoid arthritis patients as assessed by endoscopic evaluation

, , , , , , , , , , & show all
Pages 353-362 | Received 06 Apr 2011, Accepted 22 Aug 2011, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Masahiro Hasegawa, Noriyuki Horiki, Kyosuke Tanaka, Hiroki Wakabayashi, Shunsuke Tano, Masaki Katsurahara, Atsumasa Uchida, Yoshiyuki Takei & Akihiro Sudo. (2013) The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group. Modern Rheumatology 23:6, pages 1172-1178.
Read now

Articles from other publishers (3)

Min-Jeong Kim, Stal S. Shrestha, Michelle Cortes, Prachi Singh, Cheryl Morse, Jeih-San Liow, Robert L. Gladding, Chad Brouwer, Katharine Henry, Evan Gallagher, George L. Tye, Sami S. Zoghbi, Masahiro Fujita, Victor W. Pike & Robert B. Innis. (2018) Evaluation of Two Potent and Selective PET Radioligands to Image COX-1 and COX-2 in Rhesus Monkeys. Journal of Nuclear Medicine 59:12, pages 1907-1912.
Crossref
Saki Tsujimoto, Sho Mokuda, Kenichiro Matoba, Akihiro Yamada, Kazuo Jouyama, Yosuke Murata, Yoshio Ozaki, Tomoki Ito, Shosaku Nomura & Yasuaki Okuda. (2018) The prevalence of endoscopic gastric mucosal damage in patients with rheumatoid arthritis. PLOS ONE 13:7, pages e0200023.
Crossref
Shigeyoshi Tsuji, Tetsuya Tomita, Takanobu Nakase, Masayuki Hamada, Hideo Kawai & Hideki Yoshikawa. (2014) Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis. International Journal of Rheumatic Diseases 17:1, pages 44-49.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.